S.R. Schill & Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,539
Closed -$514K 85
2018
Q2
$514K Sell
9,539
-643
-6% -$32.1K 0.31% 53
2018
Q1
$463K Sell
10,182
-10
-0.1% -$429 0.29% 54
2017
Q4
$401K Buy
10,192
+287
+3% +$10.9K 0.25% 53
2017
Q3
$365K Sell
9,905
-689
-7% -$24.6K 0.22% 56
2017
Q2
$408K Buy
10,594
+930
+10% +$34.1K 0.26% 53
2017
Q1
$329K Sell
9,664
-6,971
-42% -$229K 0.21% 53
2016
Q4
$546K Buy
16,635
+6
+0% +$195 0.35% 44
2016
Q3
$537K Buy
16,629
+2,737
+20% +$88.7K 0.35% 46
2016
Q2
$429K Buy
13,892
+95
+0.7% +$2.97K 0.29% 47
2016
Q1
$413K Sell
13,797
-78
-0.6% -$2.15K 0.28% 47
2015
Q4
$384K Buy
13,875
+1,852
+15% +$52.7K 0.27% 50
2015
Q3
$367K Buy
12,023
+17
+0.1% +$592 0.26% 53
2015
Q2
$440K Buy
12,006
+3,700
+45% +$132K 0.3% 46
2015
Q1
$293K Buy
+8,306
New +$284K 0.2% 58

Other funds holding EHC

S.R. Schill & Associates's EHC Position: Q3 2018 in Review

S.R. Schill & Associates sold out of Encompass Health (EHC) in Q3 2018, closing a stake of 9,539 shares — an estimated $514K sold.

S.R. Schill & Associates first reported a position in EHC in Q1 2015 and held it in 14 quarters. The position peaked at $546K in Q4 2016. 430 funds tracked by Wall St. Rank hold EHC as of Q3 2018.

  • S.R. Schill & Associates reported no remaining Encompass Health position as of Q3 2018 after selling out during the quarter.
  • S.R. Schill & Associates sold 9,539 Encompass Health shares in Q3 2018, an estimated $514K.
  • S.R. Schill & Associates first reported a position in Encompass Health in Q1 2015 and held it in 14 quarters.
  • S.R. Schill & Associates's Encompass Health position peaked at $546K in Q4 2016.
  • 430 funds tracked by Wall St. Rank held Encompass Health as of Q3 2018.

Based on S.R. Schill & Associates's 13F filing for Q3 2018, filed 30 Oct 2018.